XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Loss for the period $ (15,760) $ (12,503)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 28 22
Stock-based compensation 121 239
Issuance of restricted shares as compensation towards directors 178
Linkage difference on principal of loans from stockholders 1
Revaluation expenses incurred from settlement of financial liabilities   1,505
Revaluation expenses related to derivative financial liabilities   2
Change in fair value of derivative liability 3,269
Amortization of debt discount and interest expense related to promissory notes 5 330
Amortization of original issue discount related to promissory note 31
Loss on warrant repurchase 99
Changes in assets and liabilities:    
Other current assets (86) 80
Accounts payable 717 1,129
Other current liabilities 272 26
Net cash used in operating activities (11,304) (8,991)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (76) (104)
Net cash used in investing activities (76) (104)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from underwritten U.S. public offerings (Note 3A) 10,715
Net proceeds from promissory note 3,000  
Series A warrant repurchase (166)
Issuance of convertible promissory notes and bifurcated conversion feature through private placement transaction 360
Issuance of convertible promissory note, bifurcated conversion and redemption features and detachable warrants through private placement transaction 4,000
Issuance of notes and warrants through private placement transaction 100
Net proceeds from private placement transaction 500
Net cash provided by financing activities 13,549 4,960
Effect of exchange rate changes on cash and cash equivalents, and restricted cash 73 (11)
Change in cash and cash equivalents, and restricted cash 2,242 (4,146)
Cash and cash equivalents, and restricted cash at beginning of the period 5,627 4,502
Cash and cash equivalents, and restricted cash, end of period 7,869 356
(a) Net cash received during the quarter for:    
Interest 120 37
(b) Non-cash activities:    
Issuance of shares and warrants as settlement of financial liabilities 238
Recognition of right for usage asset against a lease liability $ 79